Duchenne Muscular Dystrophy (DMD): 108 Frequently Asked Questions (Complete Guide 2026)

• Clumsiness.
• Problems climbing stairs.
• Trouble jumping or hopping.
• Frequent tripping or falling.
• Walking on their toes.
• Leg pain.
• Weakness in the face, shoulder, and arms.
• Inability to open or close the eyes.

Usually between ages 2–5.

- Follow Us -

Muscle tissue is replaced by fat and connective tissue (pseudohypertrophy).

Yes. Cardiomyopathy is common and requires monitoring.

Yes. Respiratory muscles weaken over time.

Typically between ages 8–14.

Some individuals experience learning disabilities or attention difficulties.

Cramping and fatigue are common.

Yes, especially in early childhood.

Yes, it is progressive.

Hip, pelvic, and thigh muscles.

Yes, especially later in progression.

Yes, especially after loss of ambulation.

Yes, contractures may develop.

No. Severity varies.

Toe-walking is thought to help maintain balance for children with DMD, who have muscle weakness in their legs. Core muscle weakness can also cause children with DMD to walk with an uneven step pattern, where one side of their body moves differently from the other.

Yes. » Swallowing Difficulty (Dysphagia) in Duchenne Muscular Dystrophy (DMD)

Mutations in the dystrophin gene. » Genetic Causes of DMD

A protein that stabilizes muscle cell membranes.

Yes — X-linked recessive inheritance.

Yes. About one-third are new mutations.

A woman with one mutated DMD gene copy. » How DMD Affects Girls and Women

Carrier mothers have a 50% chance of passing it to sons.

Rarely, but possible.

A milder form related to DMD. » Becker MD

Some dystrophin is produced. » BMD vs DMD

Missing segments of the gene. » Exon Deletion

Extra gene segments. » Types of DMD Genetic Variants

A mutation causing premature stop signals.

Mutation present in some parental cells.

Yes, especially for family planning.

Yes, through IVF with preimplantation testing.

Blood tests (high CK), genetic testing, sometimes biopsy. » Genetic Testing

An enzyme elevated when muscles break down. » Creatine Kinase

Yes, highly accurate.

Yes, via genetic testing.

In some countries and regions.

Yes, especially brothers.

Removal of tissue for analysis.

Yes, to assess muscle damage.

Neurologists and geneticists.

As soon as symptoms are noticed.

Type of gene mutation and dystrophin levels.

Yes. » Prenatal Testing for Duchenne

Yes for female relatives.

Varies, but early referral speeds confirmation.

Earlier treatment improves outcomes.

No cure yet.

Corticosteroids like prednisone and deflazacort. » Pros and Cons of Steroids (Cortisone) for Duchenne

Slow muscle degeneration.

Weight gain, bone thinning, mood changes.

A treatment that skips faulty gene sections. » Exon-Skipping

Delivery of micro-dystrophin using viral vectors.

Some are conditionally approved in certain countries.

ACE inhibitors and beta blockers.

Non-invasive ventilation like BiPAP. » Better Night’s Sleep with BiPAP Machine

Yes — critical for mobility.

Low-impact exercise is beneficial.

High-resistance training.

Yes, to prevent contractures.

After loss of ambulation if curvature progresses.

Yes, especially weight management.

Vitamin D and calcium often are.

Yes — including flu and pneumonia vaccines.

Sometimes in advanced stages.

A coordinated specialist team.

Typically annually.

Regular pulmonary function testing is recommended.

Manual and power wheelchairs. » Best Time for a Power Wheelchair in DMD

Support for comfort and quality of life.

Sometimes, depending on eligibility.

Better cardiac and respiratory management.

Encourage independence and inclusion.

Often yes (IEPs, accessibility).

Very important.

Yes, with support.

Many do with accommodations.

Ramps, accessible bathrooms.

Yes, including Parent Project Muscular Dystrophy and Muscular Dystrophy Association.

Yes, with planning.

Counseling and community support.

Disability benefits and nonprofit grants.

Moving from pediatric to adult care.

Open communication.

Yes — voice controls and assistive devices.

Extremely.

Respite care and shared responsibility.

Many families find them supportive.

Guardianship and disability planning.

With healthcare and financial advisors.

With adequate support systems.

Proactive care planning.

Gene therapy, CRISPR, exon-skipping. » Clinical Trials for Duchenne (List of All Researches)

A gene-editing technology under investigation.

Yes.

Synthetic molecules used in exon skipping.

Through neuromuscular clinics and registries.

Yes — many now live into their 30s–40s. Median life expectancy was 22.0 years (95% confidence interval). Analyses stratified by 3 time periods in which patients were born showed markedly increased life expectancy in more recent patient populations; patients born after 1990 have a median life expectancy of 28.1 years.

Advances in genetic medicine.

Yes for research and access to trials. » How to Participate in Clinical Trials for Duchenne (DMD)?

Rapidly compared to past decades.

Research aims toward disease-modifying or curative therapies.

From neuromuscular specialists and trusted advocacy groups.

During the final late non-ambulatory stage, people affected are having trouble using their hands and maintaining good posture. In all phases learning and behavioural problems may play a role as well.

Duchenne muscular dystrophy (DMD) is a progressive pediatric disorder that affects both muscle and brain. Children with DMD have mean IQ scores that are about one standard deviation lower than population means, with lower Verbal IQ than Performance IQ scores.

Duchenne muscular dystrophy is often only associated with people assigned male at birth, as it is caused by a mutation on a gene located on X chromosomes and so in people with XY chromosomes there is no other functioning gene to compensate.

Because of improved guidelines recommending comprehensive multidisciplinary care, standardization of corticosteroid treatments, disease-modifying treatments, and advances in cardiac and respiratory support, life expectancy is increasing and many young adults with DMD attend college, have careers, get married.

Many boys with DMD can be circumcised under local anesthesia.

Patients with Duchenne muscular dystrophy have a higher incidence of neurodevelopmental disorders, particularly autism spectrum and attention-deficit/hyperactivity disorders, than the general population.